Table S2. Total sample size and response rate for facility performance indicators by arm and time period
1†
% of
sample
analyzed
Performance Indicator
Total patients with revised Medical Form 5
Number missing age
Number of observations with age
Proportion of outpatients triaged
97%
Expected (36 facilities X 14 months X 2 age groups)
Number of observations
2
3
4†
5
6†
7
99%
Proportion of emergency and priority patients who were admitted,
detained, or referred
Arm B
Total
777,667
24,593
753,074
Facilitymonths
1,008
Time 0
101,445
6,633
94,812
Time 1
240,630
4,846
235,784
Time 0
204,177
8,806
195,371
Time 1
231,415
4,308
227,107
180
324
252
252
1,002
176
324
250
252
895
Facilitymonths
829
Facilitymonths
1,000
Facilitymonths
1,000
Facilitymonths
120
324
207
244
101
307
184
237
174
324
250
252
174
324
250
252
977
Facilitymonths
968
164
323
248
242
160
321
247
240
Facilitymonths
Number of observations (1,008 expected, see Indicator 1)
Estimated proportion of emergency patients who received at least
one appropriate treatment
Number of observations (1,008 expected, see Indicator 1)
Proportion of malaria suspects with a malaria test result recorded
89%
Number of observations (1,008 expected, see Indicator 1)
Estimated proportion of malaria cases who received appropriate
antimalarial treatment
Number of observations (1,008 expected, see Indicator 1)
Proportion of patients with a negative malaria test result who were
prescribed an antimalarial
99%
# Observations (1,008 expected, see Indicator 1)
Proportion of patients with a positive malaria test result who were
prescribed an antibiotic
Number of observations (1,008 expected, see Indicator 1)
97%
TableS2-1
Arm A
82%
99%
96%
Table S2. Total sample size and response rate for facility performance indicators by arm and time period
8
9
10†
11†
12
13†
14
Performance Indicator
Proportion of pneumonia suspects aged under 5 years assessed for
pneumonia
Expected (36 facilities X 14 months X 1 age group)
Number of observations
Estimated proportion of patients aged under 5 years diagnosed with
pneumonia who received appropriate antibiotic treatment
Number of observations (504 expected, see Indicator 8)
Proportion of TB suspects with a first AFB smear result
Number of observations (1008 expected, see Indicator 1)
Estimated proportion of patients with AFB smear negative results
who received empiric treatment for acute respiratory infection
Number of observations (504 expected, see Indicator 8)
Proportion of AFB positive patients prescribed initial TB treatment or
referred for TB care
All AFB positive patients in NTLP laboratory register within date
range
Denominator used in analysis
Proportion of new TB patients with a follow-up AFB smear at 2
months
All new TB patients in NTLP treatment register within date range (Jan
2009 - Dec 2010) who did not transfer-in after second month of
treatment
Denominator used in analysis
Proportion of new TB patients with treatment success
All new TB patients in NTLP treatment register within date range (Jan
2009 - Dec 2010) who did not transfer out
TableS2-2
% of
sample
analyzed
99%
98%
96%
85%
87%
86%
Arm A
Arm B
Total
Facilitymonths
504
498
Facilitymonths
494
Facilitymonths
965
Facilitymonths
429
Patients
Time 0
Time 1
Time 0
Time 1
90
85
162
162
126
125
126
126
82
161
125
126
163
313
243
246
69
147
110
103
878
205
301
167
205
764
Patients
171
267
141
185
2,601
787
456
939
419
2,224
Patients
2,333
673
418
779
354
709
399
853
372
Table S2. Total sample size and response rate for facility performance indicators by arm and time period
15
16†
17
18
19
% of
sample
analyzed
Performance Indicator
Denominator used in analysis
Proportion of TB Patients with an HIV test result recorded
All TB patients in NTLP treatment register within date range
Denominator used in analysis
Time 1
320
Time 0
563
Time 1
275
283
280
504
504
435
435
449
449
270
486
378
378
1,502
1,305
490
99%
486
99%
486
Patients
3,112
263
218
85
83
83
486
421
153
152
152
375
328
126
125
125
378
338
126
126
126
428
939
810
935
98%
3,048
Patients
421
900
809
918
1,943
1,544
Patients
232
176
558
462
522
378
631
528
100%
Proportion of patients with an HIV test result recorded
Proportion of HIV-infected pregnant women who received any ART
Number unique ANC women (de-duplicated across visits) whose
fetus has gestational age greater than 28 weeks. Includes multiple
children of same ANC woman in Early Infant Diagnosis register.
Denominator used in analysis
Proportion of HIV-infected pregnant women and infants who
received ART at delivery
TableS2-3
Total
1,645
Patients
1,671
1,668
Arm B
Time 0
487
74%
Revised Medical Form 5 expected (36 facilities X 14 months X 3 age
groups)
Number of observations - Outpatient subgroup
Number of observations - TB Suspect subgroup
ANC register expected (35 Facilities * 14 months)
Number of observations - Pregnant women
Number of observations - Partners of pregnant women
Proportion of HIV-exposed infants with an HIV test result recorded
Number of births expected among unique ANC women (deduplicated across visits). Includes multiple children of same ANC
woman in Early Infant Diagnosis register.
Time 0 = No visit in Time 1
Time 1= Had at least one visit in Time 1
Denominator used in analysis
Arm A
Facilitymonths
1,512
99%
86%
79%
Table S2. Total sample size and response rate for facility performance indicators by arm and time period
20
Performance Indicator
HIV-infected women in Maternity register
Denominator used in analysis
Live births among HIV-infected women in Maternity register
Denominator used in analysis
Proportion of HIV-infected pregnant women that started
contraception after delivery
% of
sample
analyzed
89%
90%
Number of unique HIV positive women in Post Natal Care register
(de-duplicated across visits)
Time 0 = No visit in Time 1
Time 1 = At least one visit in Time 1
21†
22†
Denominator used in analysis
Proportion of HIV-infected patients enrolled in HIV care
Number of unique HIV-infected women in ANC register (deduplicated across visits)
Denominator used in analysis
Number of unique infants in Early Infant Diagnosis register
Estimated number who were HIV-infected
Denominator used in analysis
All TB Patients in NTLP treatment register within date range, same as
Indicator 15
Estimated number who were HIV-infected
Denominator used in analysis
Proportion of HIV-infected patient and HIV-exposed infants on
cotrimoxazole
Number of unique HIV-infected women in ANC register (deduplicated across visits), same as Indicator 21
TableS2-4
60%
100%
91%
90%
Arm A
Arm B
Total
1,495
1,334
1,485
1,331
Patients
Time 0
242
211
239
210
Time 1
395
351
393
350
Time 0
392
359
391
359
Time 1
466
413
462
412
351
48
123
92
88
212
Patients
3,105
28
44
67
73
427
938
808
932
3,103
1,029
85
77
1,671
427
125
10
9
283
937
348
40
37
504
807
286
13
11
435
932
270
22
20
449
767
687
127
113
218
206
218
186
204
182
427
938
808
932
Patients
3,105
Table S2. Total sample size and response rate for facility performance indicators by arm and time period
Performance Indicator
Denominator used in analysis: Number with cotrimoxazole status
recorded at least once
% of
sample
analyzed
78%
Number of unique HIV-infected women in ANC register (deduplicated across visits), same as Indicator 21
Denominator used in analysis of HIV-exposed infants: Number of
unique HIV-infected women in ANC register with correct arm and
time period
All TB patients in NLTP treatment register within date range, same as
Indicator 15
Estimated number who were HIV-infected
Denominator used in analysis
23†
98%
Estimated number who were HIV-infected
Denominator used in analysis
All TB Patients in NTLP treatment register within date range, same as
Indicator 15
Estimated number who were HIV-infected
Denominator used in analysis
100%
91%
Time 0
312
Time 1
798
Time 0
562
Time 1
747
3,105
427
938
808
932
3,047
427
898
807
915
1,671
283
504
435
449
767
590
127
99
218
169
218
164
204
158
Patients
3,105
427
938
808
932
3,095
1,029
420
125
937
348
806
286
932
270
85
77
1,671
10
9
283
40
37
504
13
11
435
22
20
449
767
687
127
113
218
206
218
186
204
182
90%
† Denotes that the indicator was a FLEI that could have been selected as the focus CQI activities.
TableS2-5
Arm B
Total
2,419
77%
Proportion of HIV-infected, ART eligible patients on lifelong ART
Number of unique HIV-infected women in ANC register (deduplicated across visits), same as Indicator 21
Denominator used in analysis
Number of unique infants in Early Infant Diagnosis register, same as
Indicator 21
Arm A
Abbreviations: AFB=Acid-fast bacilli, ANC=Antenatal care, ART=Antiretroviral therapy, CQI=Continuous Quality Improvement, FLEI= Facility-Level
Evaluation Indicator, HIV=Human Immunodeficiency Syndrome, NTLP=National Tuberculosis and Leprosy Program, TB=Tuberculosis
TableS2-6